Predicta Biosciences Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$5.2M
- Investors
-
6
Predicta Biosciences General Information
Description
Developer of an oncology technology platform designed for cancer diagnosis and treatment. The company specializes in integrating multi-omics and liquid biopsy technologies, enabling healthcare firms to non-invasive blood-based diagnostics that replace bone marrow biopsies and guide optimal immunotherapy decisions.
Contact Information
Website
www.predictabiosciences.comCorporate Office
- Boston, MA
- United States
Corporate Office
- Boston, MA
- United States
Predicta Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 20-Jun-2024 | $5.2M | Completed | Startup |
Predicta Biosciences Comparisons
Industry
Financing
Details
Predicta Biosciences Competitors (29)
One of Predicta Biosciences’s 29 competitors is Certis (Drug Discovery), a Venture Capital-Backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Certis (Drug Discovery) | Venture Capital-Backed | San Diego, CA | ||||
| Scorpion Therapeutics | Venture Capital-Backed | Boston, MA | ||||
| Encellin | Venture Capital-Backed | Pleasanton, CA | ||||
| MiRXES | Formerly VC-backed | Singapore, Singapore | ||||
| PNP Therapeutics | Formerly VC-backed | Birmingham, AL |
Predicta Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Predicta Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Predicta Biosciences Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| American Cancer Society | Corporation | Minority | ||
| BrightEdge | Corporate Venture Capital | Minority | ||
| Engine Ventures | Venture Capital | Minority | ||
| Illumina Ventures | Venture Capital | Minority | ||
| Oetgen family | Corporation | Minority |
Predicta Biosciences FAQs
-
When was Predicta Biosciences founded?
Predicta Biosciences was founded in 2023.
-
Where is Predicta Biosciences headquartered?
Predicta Biosciences is headquartered in Boston, MA.
-
What is the size of Predicta Biosciences?
Predicta Biosciences has 7 total employees.
-
What industry is Predicta Biosciences in?
Predicta Biosciences’s primary industry is Other Healthcare Technology Systems.
-
Is Predicta Biosciences a private or public company?
Predicta Biosciences is a Private company.
-
What is Predicta Biosciences’s current revenue?
The current revenue for Predicta Biosciences is .
-
How much funding has Predicta Biosciences raised over time?
Predicta Biosciences has raised $5.2M.
-
Who are Predicta Biosciences’s investors?
American Cancer Society, BrightEdge, Engine Ventures, Illumina Ventures, and Oetgen family are 5 of 6 investors who have invested in Predicta Biosciences.
-
Who are Predicta Biosciences’s competitors?
Certis (Drug Discovery), Scorpion Therapeutics, Encellin, MiRXES, and PNP Therapeutics are some of the 29 competitors of Predicta Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
